Trial Profile
Non-randomized, open-label study in patients with TSC-associated intractable epilepsy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2010
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Epilepsy; Tuberous sclerosis
- Focus Therapeutic Use
- 30 Dec 2010 New trial record